Put companies on watchlist
Swiss Re Ltd
ISIN: CH0126881561
WKN: A1H81M
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Swiss Re Ltd · ISIN: CH0126881561 · EQS - Company News (133 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 1774459
15 November 2023 04:00PM

Swiss Re studies reveal that Electronic Health Records can speed up underwriting process by more than seven times


Swiss Re Ltd / Key word(s): Research Update/Partnership
Swiss Re studies reveal that Electronic Health Records can speed up underwriting process by more than seven times

15.11.2023 / 16:00 CET/CEST


  • Swiss Re's extensive learnings emphasize the significance of digital Electronic Health Records (EHRs) for quicker and more accurate underwriting decisions.
  • EHRs could replace Attending Physician Statements (APS) in nearly 50% of cases that originally relied on APS only.

Armonk, New York, 15 November 2023 – Studies from Swiss Re and leading life carriers reveal that Electronic Health Records (EHRs) can have a transformative impact on the traditional life & health underwriting process, resulting in quicker, non-invasive decisions for customers, more personalized risk assessment by underwriters, and maintained mortality expectations.

Results of the studies indicate that using EHRs in place of routine age and amount requirements (such as labs and Attending Physician Statements (APS)) can speed up the underwriting process from 15 days to as little as 2 days – upwards of seven times faster. The findings also show mortality benefits from using EHRs through protective value studies.

“These study results underscore the need for adaptability and forward thinking when it comes to underwriting solutions,” said Michael Bacon, Head US L&H Globals, Swiss Re. “EHRs can benefit the underwriting process by reducing redundant requirement ordering and eliminating the traditional age and amount approach.”

Over the past two years, Swiss Re put together a cross-functional team comprising of actuarial, data science and underwriting experts, to conduct a comprehensive analysis evaluating the effectiveness of using EHRs in lieu of traditional requirements. The analysis gathered EHR records on cases to compare potential risk class decisioning with EHRs to the issue decision that was based on traditional requirements, e.g. Paramed exam and labs and/or APS. The results of this analysis demonstrated that EHRs can be utilized in place of traditional age and amount requirements to provide faster, non-invasive underwriting processes for a significant volume of customers.

“At John Hancock, we have worked with Swiss Re as part of our commitment to making the underwriting and purchase process as seamless as possible," said Neal Halder, Vice President and Chief Underwriter, John Hancock. "We believe that the use of Electronic Health Records creates opportunities to offer a wider range of customers a less invasive process and faster underwriting decisions. This promising research is an important step in innovating across the underwriting process while maintaining mortality expectations.”

In order to adopt EHRs and manage the transition for underwriters, Swiss Re developed the Underwriting Ease software, which expands the use of EHRs through a visualized user interface to deliver enhanced experience to policyholders. The Underwriting Ease platform enables underwriters to streamline EHR ingestion and tie them together with disclosures in one intuitive view. This allows users to easily highlight key risks and associated severities, compile related information from various EHR sections into one place, and flexibly navigate through reports.

For more information, visit https://www.swissre.com/reinsurance/life-and-health/solutions/underwriting-ease.html. 

 

For further information please contact Swiss Re Media Relations: + 41 (0)43 285 7171 or Media_Relations@Swissre.com.
Please use this link to access Swiss Re's press releases.

Swiss Re
The Swiss Re Group is one of the world’s leading providers of reinsurance, insurance and other forms of insurance-based risk transfer, working to make the world more resilient. It anticipates and manages risk – from natural catastrophes to climate change, from ageing populations to cyber crime. The aim of the Swiss Re Group is to enable society to thrive and progress, creating new opportunities and solutions for its clients. Headquartered in Zurich, Switzerland, where it was founded in 1863, the Swiss Re Group operates through a network of around 80 offices globally.

Cautionary note on forward-looking statements
Certain statements and illustrations contained herein are forward-looking. These statements (including as to plans, objectives, targets, and trends) and illustrations provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical fact or current fact. Further information on forward looking statements can be found in the Legal Notice section of Swiss Re's website.

 



End of Media Release


Language: English
Company: Swiss Re Ltd
Mythenquai 50/60
8022 Zurich
Switzerland
Phone: +41 (0) 43 285 71 71
E-mail: Media_Relations@swissre.com
Internet: www.swissre.com
ISIN: CH0126881561
Valor: 12688156
Listed: SIX Swiss Exchange
EQS News ID: 1774459

 
End of News EQS News Service

1774459  15.11.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1774459&application_name=news&site_id=boersengefluester_html
Visual performance / price development - Swiss Re Ltd
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.